MedPath

Itraconazole

Itraconazole Capsules Rx only

Approved
Approval ID

3c0843c1-03bb-404d-b539-8680db50a452

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 2, 2023

Manufacturers
FDA

Accord Healthcare Inc.

DUNS: 604222237

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ITRACONAZOLE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16729-271
Application NumberANDA205991
Product Classification
M
Marketing Category
C73584
G
Generic Name
ITRACONAZOLE
Product Specifications
Route of AdministrationORAL
Effective DateDecember 2, 2023
FDA Product Classification

INGREDIENTS (11)

GELATINInactive
Code: 2G86QN327L
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
POLYETHYLENE GLYCOL 20000Inactive
Code: 5WKN5KL2O8
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ITRACONAZOLEActive
Quantity: 100 mg in 1 1
Code: 304NUG5GF4
Classification: ACTIB
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.